Environmental, Social And Governance Report

Overview

The report covers CMS's 2024 ESG governance, climate and resource targets, workforce development, and responsible pharmaceutical operations. It reports a 31.9% reduction in Scope 1+2 GHG emission intensity versus 2022 and discloses 7,406.7 ton CO2e of partial Scope 3 emissions for three categories. The Group reports 6,141 employees, 55.3% female employees, and 33.3% female Board members. It also reports 100% employee coverage for several ethics, information-security, and training programs.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services